Skip to main content
Log in

Impact of Thoracic Recurrent Laryngeal Node Dissection: 508 Patients with Tri-Incisional Esophagectomy

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

To evaluate the feasibility and safety of recurrent laryngeal nerve (RLN) lymph node (LN) dissection, this study compared the postoperative complications and survival between modern two-field lymphadenectomy (MTL) and modified standard two-field lymphadenectomy (MSTL) by using the propensity score matching method.

Methods

After generating propensity scores given the covariates of age, sex, tumor length, tumor location, tumor grade, and clinical stage, 254 patients with MTL were matched to 254 MSTL patients using the nearest available score matching. The LNs resected during MSTL were paraesophageal and preparatracheal LNs in the upper mediastinum, in addition to those resected during standard two-field lymphadenectomy.

Results

RLN LNs were those most commonly affected by nodal metastasis in our series (26 %). Metastasis in RLN LNs was found in around 35, 25, and 20 % of patients with cancer in the upper, middle, and lower thoracic esophagus, respectively. LN metastasis was confined to the RLN region in 49 patients. Even 35 % of patients with pT1 tumors had positive RLN LNs. MTL increased the mean number of resected LNs when compared to MSTL (29 vs.15; p < 0.001). Recurrence was more frequent in those assigned MSTL than those assigned MTL (p < 0.001). The 5-year overall survival (OS) and disease-free survival (DFS) rate for MTL were 50.7 and 42 % compared to 35.3 and 28.2 % for MSTL (both p < 0.001), respectively. Postoperative complications were more frequent following MTL when compared to the MSTL. However, no statistically significant difference in postoperative complications was observed between the two groups.

Conclusions

Adding the removal of RLN LNs might improve OS and DFS with acceptable morbidity for patients with ESCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011; 61(2): 69–90.

    Article  PubMed  Google Scholar 

  2. Jamieson GG, Lamb PJ, Thompson SK, et al. The role of lymphadenectomy in esophageal cancer. Ann Surg, 2009; 250(2): 206–9.

    Article  PubMed  Google Scholar 

  3. Akiyama H, Tsurumaru, M, Udagawa, H, Kajiyama, Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg, 1994; 220(3): 364–72.

    Article  CAS  PubMed  Google Scholar 

  4. Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg, 2004; 240(6): 962–72.

    Article  CAS  PubMed  Google Scholar 

  5. Nozoe T, Kakeji Y, Baba H, Maehara, Y. Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus, 2005; 18(4): 226–9.

    Article  CAS  PubMed  Google Scholar 

  6. Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg, 1995; 222(5): 654–62.

    Article  CAS  PubMed  Google Scholar 

  7. Fujita H, Kakegawa T, Yamana H, et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg, 1994; 18(2): 266–72.

    Article  CAS  PubMed  Google Scholar 

  8. Shiozaki H, Yano M, Tsujinaka T, et al. Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus, 2001; 14(3–4): 191–6.

    Article  CAS  PubMed  Google Scholar 

  9. Tabira Y, Yasunaga M, Tanaka M, et al. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg, 2000; 191(3): 232–7.

    Article  CAS  PubMed  Google Scholar 

  10. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265–81

    Article  PubMed  Google Scholar 

  11. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39: 33–38.

    Google Scholar 

  12. Edge SB, Byrd DR, Compton CC , et al. American Joint Committee on Cancer (AJCC) cancer staging manual, 7th ed. Chicago: Springer, Inc; 2010.

    Google Scholar 

  13. Akiyama H, et al. Surgery for Cancer of the Esophagus. Baltimore: Williams & Wilkins, 1990: 19–42.

    Google Scholar 

  14. Bumm R, Wong J. More or less surgery for esophageal cancer: extent of lymphadenectomy for squamous cell esophageal carcinoma-How much is necessary? Dis Esophagus. 1994; 7 (3):151–55

    Google Scholar 

  15. Shiraha S. Experimental studies on the lymphatics of the esophagus from the surgical point of view. Nihon Geka Hokan, 1969; 38(4): 543–64.

    CAS  PubMed  Google Scholar 

  16. Kuge K, Murakami G, Mizobuchi S, Hata, Y, Aikou, T, Sasaguri, S. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg, 2003; 125(6): 1343–9.

    Article  PubMed  Google Scholar 

  17. Fujita H, Sueyoshi S, Tanaka T,Shirouzu K. Three-field dissection for squamous cell carcinoma in the thoracic esophagus. Ann Thorac Cardiovasc Surg, 2002; 8(6): 328–35.

    PubMed  Google Scholar 

  18. Altorki NK, Zhou, X K, Stiles, B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg, 2008; 248(2): 221–6.

    Article  PubMed  Google Scholar 

  19. Stiles BM, Nasar Abu, Mirza FA, et al. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. European Journal of Cardio-Thoracic Surgery, 2012; 42 (4):659–64.

    Article  PubMed  Google Scholar 

  20. Isono K, Onoda S, Okuyama, K, Sato, H. Recurrence of intrathoracic esophageal cancer. Jpn J Clin Oncol, 1985; 15(1):49–60.

    CAS  PubMed  Google Scholar 

  21. Malassagne B, et al. Prognostic value of thoracic recurrent nerve nodal involvement in esophageal squamous cell carcinoma. J Am Coll Surg, 1997; 185(3): 244–9.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by “5010 plan” from Sun Yat-sen University (grant 2007044), which focuses on randomized control studies with multidisciplinary therapy on esophageal carcinoma. We thank the members of the Department of Thoracic Surgery, Radiology, Epidemiology and Pathology at the Sun Yat-sen University Cancer Center for cooperation and assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peng Lin.

Additional information

Zihui Tan and Guowei Ma contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, Z., Ma, G., Zhao, J. et al. Impact of Thoracic Recurrent Laryngeal Node Dissection: 508 Patients with Tri-Incisional Esophagectomy. J Gastrointest Surg 18, 187–193 (2014). https://doi.org/10.1007/s11605-013-2411-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-013-2411-2

Keywords

Navigation